BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Latest Pharma Insights


2Q Pharma Results Preview: Lilly, Biogen, Amgen, GSK And Gilead
Part two of Scrip's preview of first quarter earnings: product launches, management priorities, pricing strategies and biosimilar competition are key...
The Pink Sheet - July 21, 2017
Clif Kid Fills Zbars: Health And Wellness New Products
Vital Protein goes vegan; Herbalife offers probiotic with GanedenBC30; Endexx rolls out CBD topicals; and more news in brief.
The Rose Sheet - July 21, 2017
Enforcement, Earnings, Employment: Health And Wellness Industry News
Prison sentence in DMAA supplement case; Abbott Nutrition flat on currency exchange; Lurie takes CSPI helm; and more news in...
The Rose Sheet - July 21, 2017
Enforcement, Earnings, Employment: Health And Wellness Industry News
Prison sentence in DMAA supplement case; Abbott Nutrition flat on currency exchange; Lurie takes CSPI helm; and more news in...
The Rose Sheet - July 21, 2017
AUDIO: Device Week – July 21, 2017
On this week's Medtech Insight podcast: US Senate passes $2.8bn FDA spending bill; US approvals and clearances strong in first...
The Pink Sheet - July 21, 2017
Hot Chocolate For 'Rapunzel Locks'? UK Ad Watchdog Pounces
The Advertising Standards Authority says Cocoa Locks' hair-growth promises for its hot chocolate mix exceed authorized food health claims registered...
The Rose Sheet - July 21, 2017
SPF Eye Products Could See Uptake Following UK Application Study
Participants in a sunscreen application study missed nearly 10% of their face on average, most commonly failing to hit their...
The Rose Sheet - July 21, 2017
India Consults On ‘Essential Principles’ Ahead Of New Rules For Devices, IVDs
India’s draft guidance describes fundamental design and manufacturing requirements that, when met, indicate a medical device or IVD is safe...
The Pink Sheet - July 21, 2017
Medicare Agency Solicits Input On ICD Coverage For First Time Since 2005
The US Medicare agency opened a national coverage analysis to reconsider coverage indications for implantable cardioverter defibrillators and received input...
Medtech Insight - July 21, 2017
Medicare Agency Solicits Input On ICD Coverage For First Time Since 2005
The US Medicare agency opened a national coverage analysis to reconsider coverage indications for implantable cardioverter defibrillators and received input...
The Pink Sheet - July 21, 2017
European Formula Brands' Non-English Labels Prompt Recalls
CVS Health Baby Eczema Moisturizing Cream and products labeled as dietary supplements but found to contain drug ingredients indicated for...
The Rose Sheet - July 21, 2017
Unlocking Legalities: Ninth Circuit Allows Wider Range Of False Claim Suits
The Ninth Circuit Court of Appeals allowed False Claims Act allegations against drug manufacturers Gilead Sciences to move forward despite...
Medtech Insight - July 21, 2017
Unlocking Legalities: Ninth Circuit Allows Wider Range Of False Claim Suits
The Ninth Circuit Court of Appeals allowed False Claims Act allegations against drug manufacturers Gilead Sciences to move forward despite...
The Pink Sheet - July 21, 2017
Immuno-Oncology Outlook: Getting To The Root Of Head And Neck Cancer
As PD-1 inhibitors march toward earlier-stage head and neck cancers, researchers consider ways to improve the precision of immunotherapy through...
The Pink Sheet - July 21, 2017
EU Marketing Approval In Sight For 11 Drugs After CHMP OK; Thumbs Down For Two
The European Medicines Agency’s key scientific committee, the CHMP, has recommended for approval throughout Europe a total of 11 new...
The Pink Sheet - July 21, 2017
How Does UL Acquisition Of Emergo Consultancy Answer Conflict Of Interest Issues?
The recent acquisition of the Emergo medtech consultancy by Underwriters Laboratory has raised a few eyebrows in the sector. Can...
The Pink Sheet - July 21, 2017
Insulet, Ypsomed Split Up And Go Head-To-Head In Insulin Pump Market
Insulin pump commercial partners Insulet and Ypsomed will be parting ways after some eight years in an exclusive distribution alliance...
The Pink Sheet - July 21, 2017
Merck KGaA/Pfizer's Bavencio Set To Enter Europe's Crowded I-O Market
The highly-competitive PD-1 field in Europe is very likely to have a new player as Bavencio gets a CHMP recommendation...
The Pink Sheet - July 21, 2017
Pipeline Watch: Phase III Starts For Itacitinib And AXS-05
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...
The Pink Sheet - July 21, 2017
Pipeline Watch: Phase III Starts For Itacitinib And AXS-05
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...
The Pink Sheet - July 21, 2017
Roche's Tecentriq Gets The Double At The EU CHMP
Roche's checkpoint inhibitor Tecentriq clears the EU approval hurdle in locally advanced or metastatic urothelial carcinoma and locally advanced or...
The Pink Sheet - July 21, 2017
Regenerative Medicine Landscape
The competitive landscape for regenerative medicine continues to evolve. As private sector investment in active players continues, efforts by governments in the US and EU are helping to advance the field, including the recent passage of the 21st Century Cures Act in the US, providing a special status pathway for regenerative medicine advanced therapies. (Trends & Market Access : Trends )
Datamonitor Healthcare - July 21, 2017
Digital Update: UK Peer Pressure, US Tech Advances And EU Common Goals Put eHealth To Top Of Agenda
Funding is taking a long time to come through for the UK NHS's digital health care transformation, but as the...
The Pink Sheet - July 21, 2017
'Potential Blockbuster' Dupixent Set For EU Eczema OK
While Dupixent looks set for use in Europe for treating moderate-to-severe atopic dermatitis, analysts believe the biologic has a great...
The Pink Sheet - July 21, 2017
'Potential Blockbuster' Dupixent Set For EU Eczema OK
While Dupixent looks set for use in Europe for treating moderate-to-severe atopic dermatitis, analysts believe the biologic has a great...
The Pink Sheet - July 21, 2017
Brazil Makes Drug Prices Transparent To Strengthen Hand In Pricing Talks
Brazil wants to drive competition and lower drug prices by obliging health authorities to publish the prices paid for all...
The Pink Sheet - July 21, 2017
UK Court Shakes Up Test For Equivalent Infringement In Lilly/Actavis Case
The UK Supreme Court has shaken up the test for equivalent infringement in the UK, which is good news for...
The Pink Sheet - July 21, 2017
UCB's Bimekizumab Could Struggle With Saturated Psoriasis Market
UCB's has reported strong Phase IIb data for its novel psoriasis therapy bimekizumab, but the drug is unlikely to launch...
Scrip - July 21, 2017
UCB's Bimekizumab Could Struggle With Saturated Psoriasis Market
UCB's has reported strong Phase IIb data for its novel psoriasis therapy bimekizumab, but the drug is unlikely to launch...
Scrip - July 21, 2017
Ombudsman Probes Whether Industry Can Influence EMA In Pre-Submission Meetings
The European Medicines Agency’s practice of holding pre-submission meetings with drug developers is being investigated by the European Ombudsman, who...
The Pink Sheet - July 21, 2017
FDA's NDA And BLA Approvals: Zypitamag, Nerlynx, Vosevi, Lusduna
Original new drugs and biologics recently approved by US FDA.
The Pink Sheet - July 21, 2017
Recent And Upcoming FDA Advisory Committee Meetings
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The Pink Sheet - July 21, 2017
numares Targets 2018 For Metabolomic Bladder Cancer Test
German diagnostics firm numares AG is targeting 2018 for a launch of a bladder cancer test based on its metabolomic...
Medtech Insight - July 21, 2017
Number To Know…7
The US FDA approved seven original premarket approvals in June, the highest monthly total for the year.
Medtech Insight - July 21, 2017
Celltrion Healthcare IPO To Accelerate Celltrion's Global Biosimilar Expansion
Celltrion Healthcare's initial public offering, which is seen as the most anticipated biotech IPO in South Korea's Kosdaq market this...
Scrip - July 21, 2017

UCB's Bimekizumab Could Struggle With Saturated Psoriasis Market
UCB's has reported strong Phase IIb data for its novel psoriasis therapy bimekizumab, but the drug is unlikely to launch...
Scrip - July 21, 2017
UCB's Bimekizumab Could Struggle With Saturated Psoriasis Market
UCB's has reported strong Phase IIb data for its novel psoriasis therapy bimekizumab, but the drug is unlikely to launch...
Scrip - July 21, 2017
Celltrion Healthcare IPO To Accelerate Celltrion's Global Biosimilar Expansion
Celltrion Healthcare's initial public offering, which is seen as the most anticipated biotech IPO in South Korea's Kosdaq market this...
Scrip - July 21, 2017

2Q Pharma Results Preview: Lilly, Biogen, Amgen, GSK And Gilead
Part two of Scrip's preview of first quarter earnings: product launches, management priorities, pricing strategies and biosimilar competition are key...
The Pink Sheet - July 21, 2017
AUDIO: Device Week – July 21, 2017
On this week's Medtech Insight podcast: US Senate passes $2.8bn FDA spending bill; US approvals and clearances strong in first...
The Pink Sheet - July 21, 2017
India Consults On ‘Essential Principles’ Ahead Of New Rules For Devices, IVDs
India’s draft guidance describes fundamental design and manufacturing requirements that, when met, indicate a medical device or IVD is safe...
The Pink Sheet - July 21, 2017
Medicare Agency Solicits Input On ICD Coverage For First Time Since 2005
The US Medicare agency opened a national coverage analysis to reconsider coverage indications for implantable cardioverter defibrillators and received input...
The Pink Sheet - July 21, 2017
Unlocking Legalities: Ninth Circuit Allows Wider Range Of False Claim Suits
The Ninth Circuit Court of Appeals allowed False Claims Act allegations against drug manufacturers Gilead Sciences to move forward despite...
The Pink Sheet - July 21, 2017
Immuno-Oncology Outlook: Getting To The Root Of Head And Neck Cancer
As PD-1 inhibitors march toward earlier-stage head and neck cancers, researchers consider ways to improve the precision of immunotherapy through...
The Pink Sheet - July 21, 2017
EU Marketing Approval In Sight For 11 Drugs After CHMP OK; Thumbs Down For Two
The European Medicines Agency’s key scientific committee, the CHMP, has recommended for approval throughout Europe a total of 11 new...
The Pink Sheet - July 21, 2017
How Does UL Acquisition Of Emergo Consultancy Answer Conflict Of Interest Issues?
The recent acquisition of the Emergo medtech consultancy by Underwriters Laboratory has raised a few eyebrows in the sector. Can...
The Pink Sheet - July 21, 2017
Insulet, Ypsomed Split Up And Go Head-To-Head In Insulin Pump Market
Insulin pump commercial partners Insulet and Ypsomed will be parting ways after some eight years in an exclusive distribution alliance...
The Pink Sheet - July 21, 2017
Merck KGaA/Pfizer's Bavencio Set To Enter Europe's Crowded I-O Market
The highly-competitive PD-1 field in Europe is very likely to have a new player as Bavencio gets a CHMP recommendation...
The Pink Sheet - July 21, 2017
Pipeline Watch: Phase III Starts For Itacitinib And AXS-05
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...
The Pink Sheet - July 21, 2017
Pipeline Watch: Phase III Starts For Itacitinib And AXS-05
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...
The Pink Sheet - July 21, 2017
Roche's Tecentriq Gets The Double At The EU CHMP
Roche's checkpoint inhibitor Tecentriq clears the EU approval hurdle in locally advanced or metastatic urothelial carcinoma and locally advanced or...
The Pink Sheet - July 21, 2017
Digital Update: UK Peer Pressure, US Tech Advances And EU Common Goals Put eHealth To Top Of Agenda
Funding is taking a long time to come through for the UK NHS's digital health care transformation, but as the...
The Pink Sheet - July 21, 2017
'Potential Blockbuster' Dupixent Set For EU Eczema OK
While Dupixent looks set for use in Europe for treating moderate-to-severe atopic dermatitis, analysts believe the biologic has a great...
The Pink Sheet - July 21, 2017
'Potential Blockbuster' Dupixent Set For EU Eczema OK
While Dupixent looks set for use in Europe for treating moderate-to-severe atopic dermatitis, analysts believe the biologic has a great...
The Pink Sheet - July 21, 2017
Brazil Makes Drug Prices Transparent To Strengthen Hand In Pricing Talks
Brazil wants to drive competition and lower drug prices by obliging health authorities to publish the prices paid for all...
The Pink Sheet - July 21, 2017
UK Court Shakes Up Test For Equivalent Infringement In Lilly/Actavis Case
The UK Supreme Court has shaken up the test for equivalent infringement in the UK, which is good news for...
The Pink Sheet - July 21, 2017
Ombudsman Probes Whether Industry Can Influence EMA In Pre-Submission Meetings
The European Medicines Agency’s practice of holding pre-submission meetings with drug developers is being investigated by the European Ombudsman, who...
The Pink Sheet - July 21, 2017
FDA's NDA And BLA Approvals: Zypitamag, Nerlynx, Vosevi, Lusduna
Original new drugs and biologics recently approved by US FDA.
The Pink Sheet - July 21, 2017
Recent And Upcoming FDA Advisory Committee Meetings
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The Pink Sheet - July 21, 2017

A Learning Lab For Outcomes-Based Risk-Sharing Agreements
Merck and UnitedHealth's Optum group have partnered to explore various value constructs.
IN VIVO - July 19, 2017
The Value Lab: Moving Value-Based Health Care From Theory To Practice
Although stakeholders are interested in value-based models that link a drug’s performance to emerging evidence of improved patient outcomes, such...
IN VIVO - July 19, 2017

Medicare Agency Solicits Input On ICD Coverage For First Time Since 2005
The US Medicare agency opened a national coverage analysis to reconsider coverage indications for implantable cardioverter defibrillators and received input...
Medtech Insight - July 21, 2017
Unlocking Legalities: Ninth Circuit Allows Wider Range Of False Claim Suits
The Ninth Circuit Court of Appeals allowed False Claims Act allegations against drug manufacturers Gilead Sciences to move forward despite...
Medtech Insight - July 21, 2017
numares Targets 2018 For Metabolomic Bladder Cancer Test
German diagnostics firm numares AG is targeting 2018 for a launch of a bladder cancer test based on its metabolomic...
Medtech Insight - July 21, 2017
Number To Know…7
The US FDA approved seven original premarket approvals in June, the highest monthly total for the year.
Medtech Insight - July 21, 2017

Clif Kid Fills Zbars: Health And Wellness New Products
Vital Protein goes vegan; Herbalife offers probiotic with GanedenBC30; Endexx rolls out CBD topicals; and more news in brief.
The Rose Sheet - July 21, 2017
Enforcement, Earnings, Employment: Health And Wellness Industry News
Prison sentence in DMAA supplement case; Abbott Nutrition flat on currency exchange; Lurie takes CSPI helm; and more news in...
The Rose Sheet - July 21, 2017
Enforcement, Earnings, Employment: Health And Wellness Industry News
Prison sentence in DMAA supplement case; Abbott Nutrition flat on currency exchange; Lurie takes CSPI helm; and more news in...
The Rose Sheet - July 21, 2017
Hot Chocolate For 'Rapunzel Locks'? UK Ad Watchdog Pounces
The Advertising Standards Authority says Cocoa Locks' hair-growth promises for its hot chocolate mix exceed authorized food health claims registered...
The Rose Sheet - July 21, 2017
SPF Eye Products Could See Uptake Following UK Application Study
Participants in a sunscreen application study missed nearly 10% of their face on average, most commonly failing to hit their...
The Rose Sheet - July 21, 2017
European Formula Brands' Non-English Labels Prompt Recalls
CVS Health Baby Eczema Moisturizing Cream and products labeled as dietary supplements but found to contain drug ingredients indicated for...
The Rose Sheet - July 21, 2017

Regenerative Medicine Landscape
The competitive landscape for regenerative medicine continues to evolve. As private sector investment in active players continues, efforts by governments in the US and EU are helping to advance the field, including the recent passage of the 21st Century Cures Act in the US, providing a special status pathway for regenerative medicine advanced therapies. (Trends & Market Access : Trends )
Datamonitor Healthcare - July 21, 2017